Zomedica Corp. (ZOMDF) stock
ZOMDFOTCPharmaceutical PreparationsFiscal year ends December 31
$0.08−0.00 (-0.55%)
Close on Oct 19, 2026Market cap $77.40MP/E –Yield –
Zomedica cash
Cash and short-term investments held at the end of each period.
Zomedica's cash was $7.19M at Jun 30, 2026. For fiscal 2025 it was $9.02M, up 28.4% from the year before. Over ten years it grew 10.8% a year on average. The highest annual figure on record is $194.95M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.02M | +28.4% |
| FY2024 | Dec 31, 2024 | $7.02M | -45.8% |
| FY2023 | Dec 31, 2023 | $12.95M | -52.7% |
| FY2022 | Dec 31, 2022 | $27.40M | -85.9% |
| FY2021 | Dec 31, 2021 | $194.95M | +214.5% |
| FY2020 | Dec 31, 2020 | $61.99M | +12041.3% |
| FY2019 | Dec 31, 2019 | $510.59K | -73.7% |
| FY2018 | Dec 31, 2018 | $1.94M | -43.7% |
| FY2017 | Dec 31, 2017 | $3.45M | +6.9% |
| FY2016 | Dec 31, 2016 | $3.23M | -0.5% |
| FY2015 | Dec 31, 2015 | $3.24M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $7.19M | -11.5% |
| Q1 FY2026 | Mar 31, 2026 | $9.37M | +6.0% |
| Q4 FY2025 | Dec 31, 2025 | $9.02M | +28.4% |
| Q3 FY2025 | Sep 30, 2025 | $7.50M | -23.1% |
| Q2 FY2025 | Jun 30, 2025 | $8.13M | +2.4% |
| Q1 FY2025 | Mar 31, 2025 | $8.84M | -19.2% |
| Q4 FY2024 | Dec 31, 2024 | $7.02M | -45.8% |
| Q3 FY2024 | Sep 30, 2024 | $9.75M | -55.3% |
| Q2 FY2024 | Jun 30, 2024 | $7.94M | -71.6% |
| Q1 FY2024 | Mar 31, 2024 | $10.94M | +31.0% |
| Q4 FY2023 | Dec 31, 2023 | $12.95M | -52.7% |
| Q3 FY2023 | Sep 30, 2023 | $21.78M | -81.7% |
| Q2 FY2023 | Jun 30, 2023 | $27.95M | -85.0% |
| Q1 FY2023 | Mar 31, 2023 | $8.35M | -95.7% |
| Q4 FY2022 | Dec 31, 2022 | $27.40M | -85.9% |
| Q3 FY2022 | Sep 30, 2022 | $119.30M | -56.0% |
| Q2 FY2022 | Jun 30, 2022 | $186.76M | -32.4% |
| Q1 FY2022 | Mar 31, 2022 | $192.34M | -30.5% |
| Q4 FY2021 | Dec 31, 2021 | $194.95M | +214.5% |
| Q3 FY2021 | Sep 30, 2021 | $271.41M | +421.6% |
| Q2 FY2021 | Jun 30, 2021 | $276.21M | +849.1% |
| Q1 FY2021 | Mar 31, 2021 | $276.60M | +18380.1% |
| Q4 FY2020 | Dec 31, 2020 | $61.99M | +12041.3% |
| Q3 FY2020 | Sep 30, 2020 | $52.03M | +1991.6% |
| Q2 FY2020 | Jun 30, 2020 | $29.10M | +316.9% |
| Q1 FY2020 | Mar 31, 2020 | $1.50M | -34.8% |
| Q4 FY2019 | Dec 31, 2019 | $510.59K | -73.7% |
| Q3 FY2019 | Sep 30, 2019 | $2.49M | +372.2% |
| Q2 FY2019 | Jun 30, 2019 | $6.98M | +63.2% |
| Q1 FY2019 | Mar 31, 2019 | $2.30M | -26.7% |
| Q4 FY2018 | Dec 31, 2018 | $1.94M | -43.7% |
| Q3 FY2018 | Sep 30, 2018 | $526.82K | -88.5% |
| Q2 FY2018 | Jun 30, 2018 | $4.28M | +61.5% |
| Q1 FY2018 | Mar 31, 2018 | $3.13M | +77.4% |
| Q4 FY2017 | Dec 31, 2017 | $3.45M | +6.9% |
| Q3 FY2017 | Sep 30, 2017 | $4.56M | +40.7% |
| Q2 FY2017 | Jun 30, 2017 | $2.65M | – |
| Q1 FY2017 | Mar 31, 2017 | $1.77M | – |
| Q4 FY2016 | Dec 31, 2016 | $3.23M | – |
| Q4 FY2015 | Dec 31, 2015 | $3.24M | – |
See a number that looks wrong?